ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

TH Theratechnologies Inc

1.77
-0.02 (-1.12%)
2024年5月3日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Theratechnologies Inc TH トロント 普通株式
  前日比 前日比 % 現在値 時刻
-0.02 -1.12% 1.77 05:00:00
始値 安値 高値 終値 前日終値
1.80 1.76 1.80 1.77 1.79
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0220:30GLOBETheratechnologies to Present Long-Term Efficacy, Safety and..
2024/4/1605:15GLOBETheratechnologies Announces Mailing of Management Proxy..
2024/4/1120:30GLOBETheratechnologies to Present at the 2024 Bloom Burton & Co...
2024/4/1020:30GLOBETheratechnologies Reports Financial Results and Provides..
2024/4/0905:30GLOBETheratechnologies Preclinical Data Presentation at AACR 2024..
2024/4/0600:00GLOBETheratechnologies Appoints Elina Tea to its Board of..
2024/4/0320:30GLOBETheratechnologies to Announce First Quarter 2024 Financial..
2024/3/2820:30GLOBETheratechnologies to Present Preclinical Data at AACR on..
2024/3/2222:36GLOBETheratechnologies Announces Update on its Preclinical..
2024/3/2209:00GLOBETheratechnologies Appoints Jordan Zwick to its Board of..
2024/3/2120:30GLOBETheratechnologies Initiates Increased Dose Level in Phase 1..
2024/3/0106:34GLOBETheratechnologies Announces the Resignation of One of Its..
2024/2/2721:30GLOBETheratechnologies Receives Refusal to File Letter for..
2024/2/2121:30GLOBETheratechnologies Reports Financial Results for the Fourth..
2024/2/2021:30GLOBETheratechnologies Announces Publication in Frontiers in..
2024/2/1521:30GLOBETheratechnologies Completes Enrollment of First Six Patients..
2024/2/0621:30GLOBETheratechnologies to Announce Fourth Quarter and Full Year..
2024/1/2500:47DJNTheratechnologies Shares Sink at Open After FDA Rejects..
2024/1/2422:52DJNTheratechnologies Shares Slide Premarket as FDA Turns Away..
2024/1/2421:49DJNTheratechnologies: FDA Rejects Newer Egrifta Formulation
2024/1/2421:00GLOBETheratechnologies Receives Complete Response Letter (CRL)..
2024/1/2400:16DJNTheratechnologies Shares Fall as FDA Continues to Review..
2024/1/2321:30GLOBETheratechnologies Receives Update from FDA on Tesamorelin F8..
2024/1/0223:00APSWill This Dual-Listed Bio-Pharma Catch New Year Action?
2024/1/0221:30GLOBETheratechnologies Submits sBLA for Trogarzo® Intramuscular..
2023/12/2206:12PRNCATheratechnologies annonce le renouvellement de son..
2023/12/2206:09PRNUSTheratechnologies Announces Renewal of Shelf Prospectus and..
2023/12/1321:30GLOBETheratechnologies Announces FDA Approval of Trogarzo®..
2023/11/2421:30GLOBETheratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation..
2023/11/0101:34GLOBETheratechnologies Announces Closing of US$25 Million Public..
2023/10/2621:00GLOBETheratechnologies Announces Pricing of US$25 Million Public..
2023/10/2605:13GLOBETheratechnologies Announces Proposed Public Offering of..
2023/10/2420:00GLOBETheratechnologies Announces Operational Update
2023/10/1920:30GLOBETheratechnologies’ Ibalizumab Demonstrates..
2023/10/1620:30GLOBETheratechnologies Announces Finalization of Amendments to..
2023/10/1320:30GLOBETheratechnologies Presents Data at ID Week Showing..
2023/10/1320:00GLOBETheratechnologies Announces Results from Trogarzo®..
2023/10/1220:30GLOBETheratechnologies Announces Dosing of First Patient in..
2023/10/0420:30GLOBETheratechnologies Receives January 2024 PDUFA Goal Date for..
2023/9/2620:30GLOBETheratechnologies Reports Financial Results for the Third..
2023/9/2520:30GLOBETheratechnologies Announces Agreement in Principle with..
2023/9/2520:00GLOBETheratechnologies Submits Tesamorelin F8 Formulation sBLA..
2023/9/2020:00GLOBETheratechnologies to Present at the Cantor Fitzgerald Global..
2023/9/1905:15GLOBETheratechnologies to Announce Third Quarter 2023 Financial..
2023/9/0802:57GLOBETheratechnologies to Present at the H.C. Wainwright 25th..
2023/9/0520:00GLOBETheratechnologies Announces Certain Preliminary Q3 2023..
2023/8/3023:34GLOBETheratechnologies Announces All U.S. Oncology Clinical Sites..
2023/8/2204:24PRNUSToronto Stock Exchange, Theratechnologies Inc., View From..
2023/7/3122:00APSBiopharma Firm Completes Reverse Stock Split
2023/7/3120:00GLOBETheratechnologies Completes 1-for-4 Reverse Stock Split

最近閲覧した銘柄

Delayed Upgrade Clock